Heartwire - Episode 147: No US approval yet for apixaban for stroke prevention in atrial fibrillation

Summary: • No US approval yet for apixaban for stroke prevention in AF • FDA approves lorcaserin for the treatment of obesity • FDA refuses ACS indication for rivaroxaban—for now • Are statins less effective in women? Another meta-analysis • Not all calories are the same, new research finds And also, in brief: • US Supreme Court upholds entire Affordable Care Act** • Linagliptin noninferior to glimepiride in diabetics failing metformin • Durata failure case not so "Riata-like"